Triptorelin to prevent chemotherapy-induced ovarian failure in lymphoma patients: a prospective randomized study.
Isabelle Demeestere(Université Libre de Bruxelles), Yvon Englert(Erasmus Hospital), Pierre Zachée(Erasmus Hospital), Isabelle Gaillard(Erasmus Hospital), Julie Dechène(Erasmus Hospital), Olivier Casasnovas, Viviane De Maertelaer(Université Libre de Bruxelles), Dominique Bron, Pauline Brice(Hôpital Saint-Louis), Fedro A. Peccatori(European Institute of Oncology), Éric Van Den Neste(Erasmus Hospital), Alain Kentos(Université Libre de Bruxelles)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)
November 1, 2013
Cited by 3
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Comparison of Computed Density and Macroscopic Morphometry in Pulmonary Emphysema
|American Journal of Respiratory and Critical Care Medicine|1995|884
Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.
|Journal of Clinical Oncology|1997|706
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
Comparison of Computed Density and Microscopic Morphometry in Pulmonary Emphysema
|American Journal of Respiratory and Critical Care Medicine|1996|536